EORTC-22962-ROG

A phase III study comparing conventional versus hyperfractionated radiotherapy, with or without concomitant chemotherapy, in patients with head and neck squamous cell carcinoma.
Trial StatusAll trial activities ended
DatesDate of activation: 16-Dec-96
Closed on : 30-Apr-99
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdjuvant
Targeted Sample size994
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Radiation Oncology Group(Coordinating Group)
Protocol summaryClinicalTrials.gov
NCT number
EudraCT